St. Francis Hospital is in select company: TandemHeart is now being used in more than 90% of the “Best U.S. Heart & Heart Surgery Hospitals” as ranked by U.S. News & World Report—with more than 2,000 TandemHeart procedures performed to date at some 150 hospitals across the United States.
“TandemHeart is at the front lines of helping us treat very sick cardiac patients,” said cardiac surgeon Marc Gerdisch, M.D. “TandemHeart provides rescue for the most critically ill patients suffering from acute cardio-pulmonary injury. Rapid intervention with TandemHeart has allowed many patients to stabilize or, if needed, stay alive for heart transplant or long-term device implant. We are extremely pleased to be one of the first cardiac centers in Indiana to offer this advanced new life-saving technology.”
FDA-cleared TandemHeart can be placed rapidly by both cardiac surgeons in an operating room and interventional cardiologists in a cath lab to provide short-term circulatory support for critically ill patients. Hemodynamic support includes a high net blood-flow rate of up to eight liters per minute in the OR or five liters per minute in the catheterization lab—more than twice the amount of other available technologies—and is fully reimbursed by Medicare.
Headquartered in Pittsburgh, privately held CardiacAssist is a growing and profitable medical technology company that develops, manufactures and markets cardiac assist devices. The Company has developed the world’s first and only proprietary platform, FDA-cleared and CE-Marked TandemHeart®—which provides a short-term extracorporeal circulatory support system for both cardiologists and cardiac surgeons.
Ronald Trahan Associates, Inc.
Ron Trahan, APR, 508-359-4005, x108
KEYWORDS: United States North America Indiana Pennsylvania
INDUSTRY KEYWORDS: Health Cardiology Genetics Medical Devices